Biodexa Pharmaceuticals Plc is a drug delivery technology company. The firm is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. Its proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
11
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Biodexa Pharmaceuticals Plc - ADR market cap is $983,000.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biodexa Pharmaceuticals Plc - ADR 52 week high is $357.60 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biodexa Pharmaceuticals Plc - ADR 52 week low is $1.85 as of November 21, 2026.
Biodexa Pharmaceuticals Plc - ADR stock price today is $1.88.
Biodexa Pharmaceuticals Plc - ADR stock price yesterday was $2.00.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Biodexa Pharmaceuticals Plc - ADR's P/E ratio is -0.04.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Biodexa Pharmaceuticals Plc - ADR P/B ratio is 1476.378.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Biodexa Pharmaceuticals Plc - ADR 50-day moving average is $4.05.
Biodexa Pharmaceuticals Plc - ADR has 11 employees.